A detailed history of Fifth Third Bancorp transactions in Pfizer Inc stock. As of the latest transaction made, Fifth Third Bancorp holds 2,615,940 shares of PFE stock, worth $75.8 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
2,615,940
Previous 2,410,470 8.52%
Holding current value
$75.8 Million
Previous $66.9 Million 9.42%
% of portfolio
0.28%
Previous 0.26%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

BUY
$25.26 - $29.6 $5.19 Million - $6.08 Million
205,470 Added 8.52%
2,615,940 $73.2 Million
Q1 2024

Apr 23, 2024

SELL
$25.89 - $29.73 $1.02 Million - $1.17 Million
-39,491 Reduced 1.61%
2,410,470 $66.9 Million
Q4 2023

Jan 19, 2024

SELL
$26.13 - $33.94 $5.37 Million - $6.97 Million
-205,383 Reduced 7.73%
2,449,961 $70.5 Million
Q3 2023

Oct 31, 2023

SELL
$32.09 - $37.51 $2.56 Million - $2.99 Million
-79,638 Reduced 2.91%
2,655,344 $88.1 Million
Q2 2023

Jul 25, 2023

SELL
$36.12 - $41.79 $9.35 Million - $10.8 Million
-258,827 Reduced 8.65%
2,734,982 $100 Million
Q1 2023

Apr 24, 2023

SELL
$39.39 - $51.28 $3.33 Million - $4.33 Million
-84,533 Reduced 2.75%
2,993,809 $122 Million
Q4 2022

Jan 25, 2023

BUY
$41.75 - $54.5 $1.44 Million - $1.88 Million
34,516 Added 1.13%
3,078,342 $0
Q3 2022

Oct 25, 2022

SELL
$43.76 - $53.42 $272,274 - $332,379
-6,222 Reduced 0.2%
3,043,826 $133 Million
Q2 2022

Aug 04, 2022

SELL
$46.53 - $55.17 $1.14 Million - $1.35 Million
-24,525 Reduced 0.8%
3,050,048 $160 Million
Q1 2022

Apr 19, 2022

BUY
$45.75 - $56.69 $5.35 Million - $6.63 Million
116,875 Added 3.95%
3,074,573 $159 Million
Q4 2021

Feb 01, 2022

BUY
$41.32 - $61.25 $6.33 Million - $9.38 Million
153,111 Added 5.46%
2,957,698 $175 Million
Q3 2021

Oct 15, 2021

BUY
$39.25 - $50.42 $5.11 Million - $6.56 Million
130,113 Added 4.86%
2,804,587 $121 Million
Q2 2021

Aug 06, 2021

SELL
$35.91 - $40.68 $939,621 - $1.06 Million
-26,166 Reduced 0.97%
2,674,474 $105 Million
Q1 2021

May 07, 2021

SELL
$33.49 - $37.77 $2.43 Million - $2.74 Million
-72,661 Reduced 2.62%
2,700,640 $97.8 Million
Q4 2020

Feb 16, 2021

SELL
$33.47 - $42.56 $964,940 - $1.23 Million
-28,830 Reduced 1.03%
2,773,301 $102 Million
Q3 2020

Nov 09, 2020

BUY
$31.75 - $37.25 $5.18 Million - $6.08 Million
163,169 Added 6.18%
2,802,131 $103 Million
Q2 2020

Aug 05, 2020

BUY
$30.12 - $36.54 $775,288 - $940,539
25,740 Added 0.98%
2,638,962 $86.3 Million
Q1 2020

May 05, 2020

SELL
$27.03 - $38.62 $1.14 Million - $1.64 Million
-42,340 Reduced 1.59%
2,613,222 $85.3 Million
Q4 2019

Feb 14, 2020

SELL
$32.92 - $37.36 $790,376 - $896,976
-24,009 Reduced 0.9%
2,655,562 $104 Million
Q3 2019

Nov 14, 2019

SELL
$32.49 - $42.13 $1.2 Million - $1.56 Million
-36,971 Reduced 1.36%
2,679,571 $96.3 Million
Q2 2019

Aug 07, 2019

SELL
$36.98 - $41.52 $3.9 Million - $4.38 Million
-105,574 Reduced 3.74%
2,716,542 $118 Million
Q1 2019

May 14, 2019

SELL
$37.5 - $41.2 $500,062 - $549,402
-13,335 Reduced 0.47%
2,822,116 $120 Million
Q4 2018

Feb 14, 2019

SELL
$38.47 - $43.86 $3.38 Million - $3.85 Million
-87,807 Reduced 3.0%
2,835,451 $124 Million
Q3 2018

Nov 14, 2018

SELL
$34.47 - $41.81 $1.23 Million - $1.49 Million
-35,744 Reduced 1.21%
2,923,258 $129 Million
Q2 2018

Aug 14, 2018

SELL
$32.98 - $35.16 $4.35 Million - $4.63 Million
-131,789 Reduced 4.26%
2,959,002 $107 Million
Q1 2018

May 15, 2018

BUY
$31.91 - $37.02 $1.39 Million - $1.61 Million
43,407 Added 1.42%
3,090,791 $110 Million
Q4 2017

Feb 14, 2018

SELL
$33.26 - $35.29 $1.68 Million - $1.78 Million
-50,490 Reduced 1.63%
3,047,384 $110 Million
Q3 2017

Nov 14, 2017

SELL
$31.0 - $34.15 $214,737 - $236,557
-6,927 Reduced 0.22%
3,097,874 $111 Million
Q2 2017

Aug 11, 2017

BUY
N/A
3,104,801
3,104,801 $104 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $163B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Fifth Third Bancorp Portfolio

Follow Fifth Third Bancorp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.